期刊文献+

可溶性人类白细胞抗原-G1 cDNA的克隆及序列分析 被引量:5

Molecular cloning and sequencing of the cDNA of the soluble human leukocyte antigen-G1
下载PDF
导出
摘要 目的建立表达可溶性 HL A- G1蛋白的真核表达载体 pc DNA3- s HL A- G1。方法从绒癌细胞系 Jeg- 3细胞中提取总 RNA,借助 RT- PCR技术扩增可溶性 HL A - G1的 c DNA并把其插入真核表达载体 pc DNA 3,然后经酶切和测序法鉴定。结果经酶切鉴定及测序分析 ,证实已成功构建 pc DNA3- s HL A- G1。结论本研究成功构建可溶性 HL A - ObjectiveTo construct a recombinant plasmid pcDNA3 sHLA G1 expressing soluble HLA G1. Methods Total cell RNA was extracted from the cell line Jeg 3 and the cDNA was amplified by RT PCR; The cDNA fragment was inserted into the eukaryotic expressing vector pcDNA3 and the recombinant plasmid was identified by restriction endonucleases digestion and sequencing. Results After restriction endonucleases treatment and sequencing, it was confirmed that the pcDNA3 sHLA G1 had been constructed successfully. Conclusion In this study, the recombinant plasmid pcDNA3 sHLA G1 had been constructed successfully.
出处 《免疫学杂志》 CAS CSCD 北大核心 2001年第2期81-84,共4页 Immunological Journal
基金 国家自然科学基金!(39830 340 ) 湖北省自然科学基金!(98J10 7) 同济医科大学科研基金资助项目
关键词 可溶性HLA-G1 克隆 序列分析 CDNA 可溶性人白细胞抗原 soluble HLA G1 cloning sequencing
  • 相关文献

参考文献2

  • 1Sasaki H,Trans plantation,1999年,67卷,1期,31页
  • 2Mc Master M,J Immunol,1998年,160卷,12期,5922页

同被引文献40

  • 1夏振雄,韩军艳,王树森,曹荣华,朱珉,祁洪刚,陈栋,吴雄文,龚非力,陈实.人类白细胞抗原G1转染猪内皮细胞降低异种细胞排斥反应的研究[J].中国修复重建外科杂志,2005,19(6):486-489. 被引量:1
  • 2Arnaiz-Villena A, Martinez-Laso J, Castro MJ et al . The evolution of the MHC-G gene does not support a functional role for the complete protein [J]. Immunol Rev,2001; 183:65-75.
  • 3Casro M J, Morales P, Rojo-Amigo R et al. Homozygous HLA-G *0105N healthy individuals indicate that membrane-associated HLA-G1molecule is not necessary for survival [J] .Tissue Antigens,2000;56(3):232-239.
  • 4Lila N, Amrein C, Guillemain R et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection [J]. Circulation,2002; 105(16): 1949-1954.
  • 5Paul P, Rouas-Freiss N, Khalil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance [J]. Proc Natl Acad Sci USA, 1998; 95:4510-4515.
  • 6Urosevic M, Trojan A, Dummer R. HLA-G and its KIR ligands in cancer-another enigma yet to be solved? [ J ]. J Pathol, 2002; 196 (3): 252-253.
  • 7Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: soluble HLA-G1triggers CD95/CD95 ligand-mediated apoptosis in activated CD8 + cells by interacting with CD8 [J] .J Immunol,2000; 164:6100-6104.
  • 8Carosella E D, Moreau P, Aractingi S et al. HLA-G:a shield against inflammatory aggression [J]. Trends in Immunology, 2001; 22(10): 553-555.
  • 9HarlowE LaneD 沈关心 龚非力译.抗体实验技术指南[M].北京:科学出版社,2002.265-266.
  • 10Geraghty DE, Koller BH, Orr HT. A human major histocompatibility complex class Ⅰ gene that encode a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci USA, 1987, 84: 9145-9150.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部